Descriptor English: | BNT162 Vaccine | ||||||
Descriptor Spanish: |
Vacuna BNT162
| ||||||
Descriptor Portuguese: | Vacina BNT162 | ||||||
Descriptor French: | Vaccin BNT162 | ||||||
Entry term(s): |
Abdavomeran BNT-162A1 BNT-162B1 BNT-162B2 BNT-162C2 BNT162A1 BNT162B1 BNT162B2 BNT162C2 COVID 19 Vaccine Pfizer BioNTech COVID-19 Vaccine Pfizer-BioNTech Comirnaty Pfizer Covid-19 Vaccine Pfizer-BioNTech, COVID-19 Vaccine Pidacmeran Tozinameran Vaccine Pfizer-BioNTech, COVID-19 Vaccine, BNT162 |
||||||
Tree number(s): |
D12.776.828.868.228.500.750 D20.215.894.865.450.500.750 D20.215.894.899.085.500 D23.050.865.450.500.750 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000090982 | ||||||
Scope note: | mRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Public MeSH Note: | 2022; see COVID-19 Vaccines 2021 |
||||||
History Note: | 2022(2021) |
||||||
DeCS ID: | 59828 | ||||||
Unique ID: | D000090982 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2022/01/01 | ||||||
Date of Entry: | 2021/07/09 | ||||||
Revision Date: | 2021/12/02 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Complex Mixtures [D20]Complex Mixtures -
CHEMICALS AND DRUGS
Complex Mixtures [D20]Complex Mixtures -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
BNT162 Vaccine
- Preferred
Pidacmeran
- Narrower
Abdavomeran
- Narrower
BNT-162A1
- Narrower
Tozinameran
- Narrower
Concept UI |
M000747629 |
Scope note | mRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech. |
Preferred term | BNT162 Vaccine |
Entry term(s) |
COVID 19 Vaccine Pfizer BioNTech COVID-19 Vaccine Pfizer-BioNTech Pfizer-BioNTech, COVID-19 Vaccine Vaccine Pfizer-BioNTech, COVID-19 Vaccine, BNT162 |
Concept UI |
M000753668 |
Preferred term | Pidacmeran |
Entry term(s) |
BNT-162C2 BNT162C2 |
Concept UI |
M000753667 |
Preferred term | Abdavomeran |
Entry term(s) |
BNT-162B1 BNT162B1 |
Concept UI |
M000753665 |
Preferred term | BNT-162A1 |
Entry term(s) |
BNT162A1 |
Concept UI |
M000753666 |
Preferred term | Tozinameran |
Entry term(s) |
BNT-162B2 BNT162B2 Comirnaty Pfizer Covid-19 Vaccine |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey